Dr. Nevine M. Hanna, MD

Dr. Hanna practices at DBA Covenant Health Oncology Group in Knoxville, Tennessee.

Dr. Hanna's NPI, 1205170982, was assigned on November 19, 2012. Dr. Hanna graduated from David Geffen School of Medicine at UCLA in 2011. Dr. Hanna holds Florida license ME142392.

Dr. Hanna's primary practice is DBA Covenant Health Oncology Group, at 6450 Provision Cares Way, Knoxville, TN 37909 in Knox County. The practice phone is (865) 541-1720.

Dr. Hanna's primary practice is DBA Covenant Health Oncology Group in Knoxville, Tennessee. Dr. Hanna is also affiliated with AdventHealth Palm Coast. The medical group on file is Thompson Oncology Group. Dmand AI also links Dr. Hanna to 1 more hospital, 5 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hanna practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Hanna's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Hanna is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Hanna's licenses on file in 9 states: Florida, Ohio, Tennessee, California, Wisconsin, Missouri, North Carolina, Utah and Kansas.

Dmand AI lists bone cancer radiation, brain cancer radiation, breast cancer radiation, head & neck cancer radiation, lung cancer radiation, lymphoma radiation, pancreatic cancer radiation and prostate cancer radiation among the conditions Dr. Hanna treats.

CMS data shows 110 Medicare services from Dr. Hanna across 6 procedure codes in 2024, for 92 Medicare patients. Medicare paid $11,788 for them.

CMS counts 92 Medicare patients who saw Dr. Hanna in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hanna's median patient age at 73, with 31% women.

In 2024, Dr. Hanna wrote 50 Medicare Part D claims for 29 patients. 84% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $57 in total drug cost. In 2021, CMS named 46 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Hanna for performance year 2024, reported as part of a group. Dr. Hanna accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Hanna, published from 2015 to 2016. The most frequent topics are Disease Models, Animal. Dr. Hanna's most frequent co-authors are Matthew Brenner, MD, Parima Daroui, MD, PhD and Anthony E. Dragun, MD.

CMS Open Payments shows 17 general payments to Dr. Hanna from 9 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Novocure Inc. paid the most, $336.

Dr. Hanna graduated from David Geffen School of Medicine at UCLA in 2011.

Dr. Hanna is in network with 21 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.